
The Symani surgical robot maker said the financing will help broaden adoption of the system in the U.S. and global markets and support a clinical trial for Alzheimer’s disease.

The Symani surgical robot maker said the financing will help broaden adoption of the system in the U.S. and global markets and support a clinical trial for Alzheimer’s disease.